Hwang YH - Search Results

1

Pharmacokinetic profiles of ceftazidime after intravenous administration in patients undergoing automated peritoneal dialysis.

Kim K, Hwang YH, Ro H, Oh YK, Kim MG, Yu KS, Shin KH, Jang IJ, Shin SG, Ahn C, Oh KH. Kim K, et al. Among authors: hwang yh. Antimicrob Agents Chemother. 2011 Jun;55(6):2523-7. doi: 10.1128/AAC.01543-10. Epub 2011 Mar 14. Antimicrob Agents Chemother. 2011. PMID: 21402833 Free PMC article.

2

Characterization of microsatellite markers to diagnose ADPKD.

Bae Y, Kim H, Paik M, Lee J, Hwang D, Hwang Y, Ahn C, Kang S. Bae Y, et al. Mol Cell Probes. 2004 Jun;18(3):155-9. doi: 10.1016/j.mcp.2003.12.001. Mol Cell Probes. 2004. PMID: 15135448

3

SLC12A3 (solute carrier family 12 member [sodium/chloride] 3) polymorphisms are associated with end-stage renal disease in diabetic nephropathy.

Kim JH, Shin HD, Park BL, Moon MK, Cho YM, Hwang YH, Oh KW, Kim SY, Lee HK, Ahn C, Park KS. Kim JH, et al. Among authors: hwang yh. Diabetes. 2006 Mar;55(3):843-8. doi: 10.2337/diabetes.55.03.06.db05-1013. Diabetes. 2006. PMID: 16505253

4

MCP-1 and RANTES polymorphisms in Korean diabetic end-stage renal disease.

Joo KW, Hwang YH, Kim JH, Oh KH, Kim H, Shin HD, Chung WK, Yang J, Park KS, Ahn C. Joo KW, et al. Among authors: hwang yh. J Korean Med Sci. 2007 Aug;22(4):611-5. doi: 10.3346/jkms.2007.22.4.611. J Korean Med Sci. 2007. PMID: 17728497 Free PMC article.

5

Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients.

Oh KH, Moon JY, Oh J, Kim SG, Hwang YH, Kim S, Lee JS, Ahn C. Oh KH, et al. Among authors: hwang yh. Nephrol Dial Transplant. 2008 Jul;23(7):2356-64. doi: 10.1093/ndt/gfm921. Epub 2008 Jan 4. Nephrol Dial Transplant. 2008. PMID: 18178604

6

Could solutions low in glucose degradation products preserve residual renal function in incident peritoneal dialysis patients? A 1-year multicenter prospective randomized controlled trial (Balnet Study).

Kim SG, Kim S, Hwang YH, Kim K, Oh JE, Chung W, Oh KH, Kim HJ, Ahn C; Korean Balnet Study Group. Kim SG, et al. Among authors: hwang yh. Perit Dial Int. 2008 Jun;28 Suppl 3:S117-22. Perit Dial Int. 2008. PMID: 18552239 Clinical Trial.

7

Effects of interleukin-6 T15A single nucleotide polymorphism on baseline peritoneal solute transport rate in incident peritoneal dialysis patients.

Hwang YH, Son MJ, Yang J, Kim K, Chung W, Joo KW, Kim Y, Ahn C, Oh KH. Hwang YH, et al. Perit Dial Int. 2009 Jan-Feb;29(1):81-8. Perit Dial Int. 2009. PMID: 19164257

8

Transcatheter arterial embolization therapy for a massive polycystic liver in autosomal dominant polycystic kidney disease patients.

Park HC, Kim CW, Ro H, Moon JY, Oh KH, Kim Y, Lee JS, Yin YH, Jae HJ, Chung JW, Ahn C, Hwang YH. Park HC, et al. Among authors: hwang yh. J Korean Med Sci. 2009 Feb;24(1):57-61. doi: 10.3346/jkms.2009.24.1.57. Epub 2009 Feb 28. J Korean Med Sci. 2009. PMID: 19270814 Free PMC article.

9

Genetic polymorphisms of hypoxia-inducible factor-1 alpha and cardiovascular disease in hemodialysis patients.

Zheng ZL, Hwang YH, Kim SK, Kim S, Son MJ, Ro H, Sung SA, Lee HH, Chung WK, Joo KW, Yang J. Zheng ZL, et al. Among authors: hwang yh. Nephron Clin Pract. 2009;113(2):c104-11. doi: 10.1159/000228542. Epub 2009 Jul 14. Nephron Clin Pract. 2009. PMID: 19602906

10

Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation.

Hwang YH, Ro H, Choi I, Kim H, Oh KH, Hwang JI, Park MH, Kim S, Yang J, Ahn C. Hwang YH, et al. Among authors: hwang ji. Transplantation. 2009 Sep 15;88(5):699-705. doi: 10.1097/TP.0b013e3181b2f34a. Transplantation. 2009. PMID: 19741468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

843 results

Search Page

Filters